Skip to main content

Adtalem Global Education Inc

For the period ended Mar 31, 2025. Filed May 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

CVSA$116.50+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

(in thousands)

​​​​​​​
​ · ​ · Nine Months Ended
​ · ​ · March 31,
​ · ​ · 2025 · ​ · 2024
Operating activities:​​​​​​
Net income​$182,853​$87,358
Income from discontinued operations​(4,638)​(245)
Income from continuing operations​​178,215​​87,113
Adjustments to reconcile net income to net cash provided by operating activities:​​​​
Stock-based compensation​31,181​19,405
Amortization and impairments to operating lease assets​​25,330​​24,705
Depreciation​30,267​29,879
Amortization of acquired intangible assets​8,415​28,296
Amortization of debt discount and issuance costs​​4,995​​4,550
Provision for bad debts​​46,854​​35,741
Deferred income taxes​19,994​(4,650)
Loss on disposals and impairments of property and equipment​2,522​50
Gain on investments​​(268)​​(1,281)
Unrealized loss on assets held for sale​​—​​647
Changes in assets and liabilities:​​​​
Accounts and financing receivables​(80,613)​(73,661)
Prepaid expenses and other current assets​5,727​(2,484)
Cloud computing implementation assets​(21,959)​(19,262)
Accounts payable​(9,978)​12,632
Accrued payroll and benefits​​1,406​​15,671
Accrued liabilities​(10,449)​39,748
Deferred revenue​66,081​60,935
Operating lease liabilities​​(17,839)​​(28,448)
Other assets and liabilities​(6,068)​(2,475)
Net cash provided by operating activities-continuing operations​273,813​227,111
Net cash provided by operating activities-discontinued operations​4,394​8,396
Net cash provided by operating activities​278,207​235,507
Investing activities:​​​​​
Capital expenditures​(31,337)​(32,316)
Proceeds from sales of marketable securities​3,120​626
Purchases of marketable securities​(2,048)​(498)
Net cash used in investing activities​(30,265)​(32,188)
Financing activities:​​​​​
Proceeds from exercise of stock options​10,008​15,412
Employee taxes paid on withholding shares​(12,457)​(6,600)
Proceeds from stock issued under Colleague Stock Purchase Plan​922​581
Repurchases of common stock for treasury​(146,436)​(250,463)
Proceeds from issuance of long-term debt​9,873​1,896
Repayments of long-term debt​(109,873)​(51,896)
Net cash used in financing activities​(247,963)​(291,070)
Net decrease in cash, cash equivalents and restricted cash​(21)​(87,751)
Cash, cash equivalents and restricted cash at beginning of period​221,202​275,075
Cash, cash equivalents and restricted cash at end of period​$221,181​$187,324
Non-cash investing and financing activities:​​​​​​
Accrued capital expenditures​$12,410​$6,217
Accrued liability for repurchases of common stock​$4,879​$2,995
Accrued excise tax on share repurchases​$1,055​$3,257
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.